Explore

Capbase

TCM Life Science Inc. — Funding, Investors & Profile — Capbase

Private

Private securities offering disclosed via SEC Form D.

Biotechnology

$16.7KUncited—Raised (recorded)

UndisclosedUncited—Last valuation

TCM Life Science Inc. filed a Form D notice of exempt offering with the SEC.

1 round

1 round recorded · latest Private placement (Form D), Oct 2026 · $16.7K recorded

No investors recorded yet for TCM Life Science Inc..

Leadership

Ya-Chun WangExecutive OfficerSince 2026Uncited—

Huan-Chin HsuDirectorSince 2026Uncited—

TCM Life Science Inc. has no recorded acquisitions.

Still private — no exit on record.

No diversity signals recorded yet for TCM Life Science Inc..

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.